Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025
December 20, 2024 13:15 ET
|
Syntekabio USA Inc.
NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech...
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
May 23, 2024 10:00 ET
|
Syntekabio USA Inc.
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...